BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 2:47:00 PM | Browse: 864 | Download: 647
Publication Name World Journal of Gastroenterology
Manuscript ID 6756
Country Italy
Received
2013-10-28 13:58
Peer-Review Started
2013-10-28 15:05
To Make the First Decision
2014-01-09 20:08
Return for Revision
2014-01-19 20:45
Revised
2014-02-13 02:00
Second Decision
2014-03-13 13:51
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-03-13 16:45
Articles in Press
2014-05-23 11:03
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-03-25 18:17
Typeset the Manuscript
2014-07-17 11:54
Publish the Manuscript Online
2014-08-07 10:34
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Topic Highlights
Article Title Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer
Manuscript Source Invited Manuscript
All Author List Alfonso De Stefano and Chiara Carlomagno
Funding Agency and Grant Number
Corresponding Author Alfonso De Stefano, MD, PhD, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Sergio Pansini, 5, 80131 Naples, Italy. alfonso.destefano@unina.it
Key Words KRAS; Anti-epidermal growth factor receptor; Metastatic colorectal cancer; Biomarkers
Core Tip This is a review underlining the importance of biomarkers in the treatment of metastatic colorectal cancer. All most recent findings are described to offer a contribution to define a correct approach to anti-epidermal growth factor receptor based treatment.
Publish Date 2014-08-07 10:34
Citation De Stefano A, Carlomagno C. Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer. World J Gastroenterol 2014; 20(29): 9732-9743
URL http://www.wjgnet.com/1007-9327/full/v20/i29/9732.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i29.9732
Full Article (PDF) WJG-20-9732.pdf
Full Article (Word) WJG-20-9732.doc
Manuscript File 6756-Review.docx
Answering Reviewers 6756-Answering reviewers.pdf
Copyright License Agreement 6756-Copyright assignment.pdf
Peer-review Report 6756-Peer reviewer(s).pdf
Scientific Editor Work List 6756-Scientific editor work list.doc